These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3079408)

  • 1. Anthracyclines.
    Myers C
    Cancer Chemother Biol Response Modif; 1987; 9():36-49. PubMed ID: 3079408
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthracyclines.
    Myers C
    Cancer Chemother Biol Response Modif; 1988; 10():33-9. PubMed ID: 3079388
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthracyclines.
    Myers CE
    Cancer Chemother Biol Response Modif; 1992; 13():45-52. PubMed ID: 1389917
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and antiproliferative activity of a novel N-acyl derivative of doxorubicin].
    Shcherbakov VM; Devichenskiĭ VM; Vorontsov EA; Kuznetsov SL; Kriukov LN
    Bioorg Khim; 1999 Mar; 25(3):226-9. PubMed ID: 10382042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular membrane permeability of anthracyclines does not correlate with their delivery in a tissue-isolated tumor.
    Heijn M; Roberge S; Jain RK
    Cancer Res; 1999 Sep; 59(17):4458-63. PubMed ID: 10485498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological mechanisms of Doxorubicin activity (DOX) - current state of knowledge].
    Łubgan D; Marczak A; Walczak M; Distel L; Jóźwiak Z
    Przegl Lek; 2006; 63(9):782-8. PubMed ID: 17479870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
    Schwartz EL; Sartorelli AC
    Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
    Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study on in vitro chemosensitivity of urotherial cancers to three anthracyclines].
    Yamada S; Deguchi T; Nezasa S; Kawamoto S; Ehara H; Takahashi Y; Okano M; Fujimoto Y; Isogai K; Kawada Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1339-41. PubMed ID: 8831750
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145.
    Floryk D; Huberman E
    Cancer Lett; 2006 Jan; 231(1):20-9. PubMed ID: 16356827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance.
    Bielack SS; Kallenbach K; Looft G; Erttmann R; Winkler K
    Anticancer Res; 1995; 15(4):1279-84. PubMed ID: 7654009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiation.
    Teillaud JL; Gruel N; Moncuit J; Mishal Z; Fridman WH; Lampidis TJ; Tapiero H
    Biomed Pharmacother; 1998; 52(6):282-90. PubMed ID: 9755828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
    Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
    J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
    Niitsu N; Umeda M; Honma Y
    Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
    Ogawa T; Tokuda M; Tomizawa K; Matsui H; Itano T; Konishi R; Nagahata S; Hatase O
    Biochem Biophys Res Commun; 1998 Aug; 249(1):226-30. PubMed ID: 9705862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R
    Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocytes as carriers of anthracycline antibiotics].
    Tikhonova AG; Aleksandrovich IuG; Vuĭmo TA; Sinauridze EI; Ataullakhanov FI
    Ter Arkh; 2008; 80(7):91-4. PubMed ID: 18763609
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of anthracyclines by cellular peroxidase.
    Reszka KJ; Wagner BA; Teesch LM; Britigan BE; Spitz DR; Burns CP
    Cancer Res; 2005 Jul; 65(14):6346-53. PubMed ID: 16024637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose anthracyclines may block HIF-1 and stop tumor growth.
    Hede K
    J Natl Cancer Inst; 2009 Mar; 101(6):368-70. PubMed ID: 19276456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.